Table of Content

1 Polypeptide Drug Market Overview
1.1 Polypeptide Drug Product Scope
1.2 Polypeptide Drug Segment by Type
1.2.1 Global Polypeptide Drug Sales by Type (2016 & 2021 & 2027)
1.2.2 Injection
1.2.3 Nasal Administration
1.2.4 Lung Administration
1.2.5 Oral Administration
1.2.6 Transdermal Administration
1.3 Polypeptide Drug Segment by Application
1.3.1 Global Polypeptide Drug Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Immunity Regulating Medicine (Allergy Infection and Immune)
1.3.3 Digestive System Drugs (Gastrointestinal Type)
1.3.4 Bone and Connective Tissue Types (Thyroid hormones Drug)
1.3.5 Gynecologic or Obstetric Drug
1.3.6 Tumor Drug
1.3.7 Urinary System Drug
1.3.8 Metabolic Drug (Insulin and Other Hypoglycemic Agents)
1.4 Polypeptide Drug Market Estimates and Forecasts (2016-2027)
1.4.1 Global Polypeptide Drug Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Polypeptide Drug Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Polypeptide Drug Price Trends (2016-2027)

2 Polypeptide Drug Estimates and Forecasts by Region
2.1 Global Polypeptide Drug Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Polypeptide Drug Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Polypeptide Drug Sales Market Share by Region (2016-2021)
2.2.2 Global Polypeptide Drug Revenue Market Share by Region (2016-2021)
2.3 Global Polypeptide Drug Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Polypeptide Drug Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Polypeptide Drug Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Polypeptide Drug Estimates and Projections (2016-2027)
2.4.2 Europe Polypeptide Drug Estimates and Projections (2016-2027)
2.4.3 China Polypeptide Drug Estimates and Projections (2016-2027)
2.4.4 Japan Polypeptide Drug Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Polypeptide Drug Estimates and Projections (2016-2027)
2.4.6 India Polypeptide Drug Estimates and Projections (2016-2027)

3 Global Polypeptide Drug Competition Landscape by Players
3.1 Global Top Polypeptide Drug Players by Sales (2016-2021)
3.2 Global Top Polypeptide Drug Players by Revenue (2016-2021)
3.3 Global Polypeptide Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Polypeptide Drug as of 2020)
3.4 Global Polypeptide Drug Average Price by Company (2016-2021)
3.5 Manufacturers Polypeptide Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Polypeptide Drug Market Size by Type
4.1 Global Polypeptide Drug Historic Market Review by Type (2016-2021)
4.1.1 Global Polypeptide Drug Sales Market Share by Type (2016-2021)
4.1.2 Global Polypeptide Drug Revenue Market Share by Type (2016-2021)
4.1.3 Global Polypeptide Drug Price by Type (2016-2021)
4.2 Global Polypeptide Drug Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Polypeptide Drug Sales Forecast by Type (2022-2027)
4.2.2 Global Polypeptide Drug Revenue Forecast by Type (2022-2027)
4.2.3 Global Polypeptide Drug Price Forecast by Type (2022-2027)

5 Global Polypeptide Drug Market Size by Application
5.1 Global Polypeptide Drug Historic Market Review by Application (2016-2021)
5.1.1 Global Polypeptide Drug Sales Market Share by Application (2016-2021)
5.1.2 Global Polypeptide Drug Revenue Market Share by Application (2016-2021)
5.1.3 Global Polypeptide Drug Price by Application (2016-2021)
5.2 Global Polypeptide Drug Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Polypeptide Drug Sales Forecast by Application (2022-2027)
5.2.2 Global Polypeptide Drug Revenue Forecast by Application (2022-2027)
5.2.3 Global Polypeptide Drug Price Forecast by Application (2022-2027)

6 North America Polypeptide Drug Market Facts & Figures
6.1 North America Polypeptide Drug Sales by Company
6.1.1 North America Polypeptide Drug Sales by Company (2016-2021)
6.1.2 North America Polypeptide Drug Revenue by Company (2016-2021)
6.2 North America Polypeptide Drug Sales Breakdown by Type
6.2.1 North America Polypeptide Drug Sales Breakdown by Type (2016-2021)
6.2.2 North America Polypeptide Drug Sales Breakdown by Type (2022-2027)
6.3 North America Polypeptide Drug Sales Breakdown by Application
6.3.1 North America Polypeptide Drug Sales Breakdown by Application (2016-2021)
6.3.2 North America Polypeptide Drug Sales Breakdown by Application (2022-2027)

7 Europe Polypeptide Drug Market Facts & Figures
7.1 Europe Polypeptide Drug Sales by Company
7.1.1 Europe Polypeptide Drug Sales by Company (2016-2021)
7.1.2 Europe Polypeptide Drug Revenue by Company (2016-2021)
7.2 Europe Polypeptide Drug Sales Breakdown by Type
7.2.1 Europe Polypeptide Drug Sales Breakdown by Type (2016-2021)
7.2.2 Europe Polypeptide Drug Sales Breakdown by Type (2022-2027)
7.3 Europe Polypeptide Drug Sales Breakdown by Application
7.3.1 Europe 131 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 131 Sales Breakdown by Application (2022-2027)

8 China Polypeptide Drug Market Facts & Figures
8.1 China Polypeptide Drug Sales by Company
8.1.1 China Polypeptide Drug Sales by Company (2016-2021)
8.1.2 China Polypeptide Drug Revenue by Company (2016-2021)
8.2 China Polypeptide Drug Sales Breakdown by Type
8.2.1 China Polypeptide Drug Sales Breakdown by Type (2016-2021)
8.2.2 China Polypeptide Drug Sales Breakdown by Type (2022-2027)
8.3 China Polypeptide Drug Sales Breakdown by Application
8.3.1 China 156 Sales Breakdown by Application (2016-2021)
8.3.2 China 156 Sales Breakdown by Application (2022-2027)

9 Japan Polypeptide Drug Market Facts & Figures
9.1 Japan Polypeptide Drug Sales by Company
9.1.1 Japan Polypeptide Drug Sales by Company (2016-2021)
9.1.2 Japan Polypeptide Drug Revenue by Company (2016-2021)
9.2 Japan Polypeptide Drug Sales Breakdown by Type
9.2.1 Japan Polypeptide Drug Sales Breakdown by Type (2016-2021)
9.2.2 Japan Polypeptide Drug Sales Breakdown by Type (2022-2027)
9.3 Japan Polypeptide Drug Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Polypeptide Drug Market Facts & Figures
10.1 Southeast Asia Polypeptide Drug Sales by Company
10.1.1 Southeast Asia Polypeptide Drug Sales by Company (2016-2021)
10.1.2 Southeast Asia Polypeptide Drug Revenue by Company (2016-2021)
10.2 Southeast Asia Polypeptide Drug Sales Breakdown by Type
10.2.1 Southeast Asia Polypeptide Drug Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Polypeptide Drug Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Polypeptide Drug Sales Breakdown by Application
10.3.1 Southeast Asia MT Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia MT Sales Breakdown by Application (2022-2027)

11 India Polypeptide Drug Market Facts & Figures
11.1 India Polypeptide Drug Sales by Company
11.1.1 India Polypeptide Drug Sales by Company (2016-2021)
11.1.2 India Polypeptide Drug Revenue by Company (2016-2021)
11.2 India Polypeptide Drug Sales Breakdown by Type
11.2.1 India Polypeptide Drug Sales Breakdown by Type (2016-2021)
11.2.2 India Polypeptide Drug Sales Breakdown by Type (2022-2027)
11.3 India Polypeptide Drug Sales Breakdown by Application
11.3.1 India Polypeptide Drug Sales Breakdown by Application (2016-2021)
11.3.2 India Polypeptide Drug Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Polypeptide Drug Business
12.1 Novartis
12.1.1 Novartis Corporation Information
12.1.2 Novartis Business Overview
12.1.3 Novartis Polypeptide Drug Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Novartis Polypeptide Drug Products Offered
12.1.5 Novartis Recent Development
12.2 Merck Serono
12.2.1 Merck Serono Corporation Information
12.2.2 Merck Serono Business Overview
12.2.3 Merck Serono Polypeptide Drug Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Merck Serono Polypeptide Drug Products Offered
12.2.5 Merck Serono Recent Development
12.3 Ferring Pharmaceuticals
12.3.1 Ferring Pharmaceuticals Corporation Information
12.3.2 Ferring Pharmaceuticals Business Overview
12.3.3 Ferring Pharmaceuticals Polypeptide Drug Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Ferring Pharmaceuticals Polypeptide Drug Products Offered
12.3.5 Ferring Pharmaceuticals Recent Development
12.4 Ipsen PHarma Biotech
12.4.1 Ipsen PHarma Biotech Corporation Information
12.4.2 Ipsen PHarma Biotech Business Overview
12.4.3 Ipsen PHarma Biotech Polypeptide Drug Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Ipsen PHarma Biotech Polypeptide Drug Products Offered
12.4.5 Ipsen PHarma Biotech Recent Development
12.5 Lilly
12.5.1 Lilly Corporation Information
12.5.2 Lilly Business Overview
12.5.3 Lilly Polypeptide Drug Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Lilly Polypeptide Drug Products Offered
12.5.5 Lilly Recent Development
12.6 Asahi Kasei
12.6.1 Asahi Kasei Corporation Information
12.6.2 Asahi Kasei Business Overview
12.6.3 Asahi Kasei Polypeptide Drug Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Asahi Kasei Polypeptide Drug Products Offered
12.6.5 Asahi Kasei Recent Development
12.7 AstraZeneca
12.7.1 AstraZeneca Corporation Information
12.7.2 AstraZeneca Business Overview
12.7.3 AstraZeneca Polypeptide Drug Sales, Revenue and Gross Margin (2016-2021)
12.7.4 AstraZeneca Polypeptide Drug Products Offered
12.7.5 AstraZeneca Recent Development
12.8 SciClone Pharmaceuticals
12.8.1 SciClone Pharmaceuticals Corporation Information
12.8.2 SciClone Pharmaceuticals Business Overview
12.8.3 SciClone Pharmaceuticals Polypeptide Drug Sales, Revenue and Gross Margin (2016-2021)
12.8.4 SciClone Pharmaceuticals Polypeptide Drug Products Offered
12.8.5 SciClone Pharmaceuticals Recent Development
12.9 Takeda
12.9.1 Takeda Corporation Information
12.9.2 Takeda Business Overview
12.9.3 Takeda Polypeptide Drug Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Takeda Polypeptide Drug Products Offered
12.9.5 Takeda Recent Development
12.10 Roche
12.10.1 Roche Corporation Information
12.10.2 Roche Business Overview
12.10.3 Roche Polypeptide Drug Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Roche Polypeptide Drug Products Offered
12.10.5 Roche Recent Development
12.11 Sanofi
12.11.1 Sanofi Corporation Information
12.11.2 Sanofi Business Overview
12.11.3 Sanofi Polypeptide Drug Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Sanofi Polypeptide Drug Products Offered
12.11.5 Sanofi Recent Development

13 Polypeptide Drug Manufacturing Cost Analysis
13.1 Polypeptide Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Polypeptide Drug
13.4 Polypeptide Drug Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Polypeptide Drug Distributors List
14.3 Polypeptide Drug Customers

15 Market Dynamics
15.1 Polypeptide Drug Market Trends
15.2 Polypeptide Drug Drivers
15.3 Polypeptide Drug Market Challenges
15.4 Polypeptide Drug Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Polypeptide Drug Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Polypeptide Drug Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Polypeptide Drug Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Polypeptide Drug Sales (MT) by Region (2016-2021)
Table 5. Global Polypeptide Drug Sales Market Share by Region (2016-2021)
Table 6. Global Polypeptide Drug Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Polypeptide Drug Revenue Share by Region (2016-2021)
Table 8. Global Polypeptide Drug Sales (MT) Forecast by Region (2022-2027)
Table 9. Global Polypeptide Drug Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Polypeptide Drug Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Polypeptide Drug Revenue Share Forecast by Region (2022-2027)
Table 12. Global Polypeptide Drug Sales (MT) of Key Companies (2016-2021)
Table 13. Global Polypeptide Drug Sales Share by Company (2016-2021)
Table 14. Global Polypeptide Drug Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Polypeptide Drug Revenue Share by Company (2016-2021)
Table 16. Global Polypeptide Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Polypeptide Drug as of 2020)
Table 17. Global Polypeptide Drug Average Price (USD/MT) of Key Company (2016-2021)
Table 18. Manufacturers Polypeptide Drug Manufacturing Sites and Area Served
Table 19. Manufacturers Polypeptide Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Polypeptide Drug Sales (MT) by Type (2016-2021)
Table 22. Global Polypeptide Drug Sales Share by Type (2016-2021)
Table 23. Global Polypeptide Drug Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Polypeptide Drug Price (USD/MT) by Type (2016-2021)
Table 25. Global Polypeptide Drug Sales Share by Type (2022-2027)
Table 26. Global Polypeptide Drug Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Polypeptide Drug Revenue Share by Type (2022-2027)
Table 28. Global Polypeptide Drug Price (USD/MT) by Type (2022-2027)
Table 29. Global Polypeptide Drug Sales (MT) by Application (2016-2021)
Table 30. Global Polypeptide Drug Sales Share by Application (2016-2021)
Table 31. Global Polypeptide Drug Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Polypeptide Drug Price (USD/MT) by Application (2016-2021)
Table 33. Global Polypeptide Drug Sales (MT) by Application (2022-2027)
Table 34. Global Polypeptide Drug Sales Share by Application (2022-2027)
Table 35. Global Polypeptide Drug Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Polypeptide Drug Revenue Share by Application (2022-2027)
Table 37. Global Polypeptide Drug Price (USD/MT) by Application (2022-2027)
Table 38. North America Polypeptide Drug Sales (MT) by Company (2016-2021)
Table 39. North America Polypeptide Drug Sales Market Share by Company (2016-2021)
Table 40. North America Polypeptide Drug Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Polypeptide Drug Revenue Market Share by Company (2016-2021)
Table 42. North America Polypeptide Drug Sales by Type (2016-2021) & (MT)
Table 43. North America Polypeptide Drug Sales Market Share by Type (2016-2021)
Table 44. North America Polypeptide Drug Sales by Type (2022-2027) & (MT)
Table 45. North America Polypeptide Drug Sales Market Share by Type (2022-2027)
Table 46. North America Polypeptide Drug Sales by Application (2016-2021) & (MT)
Table 47. North America Polypeptide Drug Sales Market Share by Application (2016-2021)
Table 48. North America Polypeptide Drug Sales by Application (2022-2027) & (MT)
Table 49. North America Polypeptide Drug Sales Market Share by Application (2022-2027)
Table 50. Europe Polypeptide Drug Sales (MT) by Company (2016-2021)
Table 51. Europe Polypeptide Drug Sales Market Share by Company (2016-2021)
Table 52. Europe Polypeptide Drug Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Polypeptide Drug Revenue Market Share by Company (2016-2021)
Table 54. Europe Polypeptide Drug Sales by Type (2016-2021) & (MT)
Table 55. Europe Polypeptide Drug Sales Market Share by Type (2016-2021)
Table 56. Europe Polypeptide Drug Sales by Type (2022-2027) & (MT)
Table 57. Europe Polypeptide Drug Sales Market Share by Type (2022-2027)
Table 58. Europe Polypeptide Drug Sales by Application (2016-2021) & (MT)
Table 59. Europe Polypeptide Drug Sales Market Share by Application (2016-2021)
Table 60. Europe Polypeptide Drug Sales by Application (2022-2027) & (MT)
Table 61. Europe Polypeptide Drug Sales Market Share by Application (2022-2027)
Table 62. China Polypeptide Drug Sales (MT) by Company (2016-2021)
Table 63. China Polypeptide Drug Sales Market Share by Company (2016-2021)
Table 64. China Polypeptide Drug Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Polypeptide Drug Revenue Market Share by Company (2016-2021)
Table 66. China Polypeptide Drug Sales by Type (2016-2021) & (MT)
Table 67. China Polypeptide Drug Sales Market Share by Type (2016-2021)
Table 68. China Polypeptide Drug Sales by Type (2022-2027) & (MT)
Table 69. China Polypeptide Drug Sales Market Share by Type (2022-2027)
Table 70. China Polypeptide Drug Sales by Application (2016-2021) & (MT)
Table 71. China Polypeptide Drug Sales Market Share by Application (2016-2021)
Table 72. China Polypeptide Drug Sales by Application (2022-2027) & (MT)
Table 73. China Polypeptide Drug Sales Market Share by Application (2022-2027)
Table 74. Japan Polypeptide Drug Sales (MT) by Company (2016-2021)
Table 75. Japan Polypeptide Drug Sales Market Share by Company (2016-2021)
Table 76. Japan Polypeptide Drug Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Polypeptide Drug Revenue Market Share by Company (2016-2021)
Table 78. Japan Polypeptide Drug Sales by Type (2016-2021) & (MT)
Table 79. Japan Polypeptide Drug Sales Market Share by Type (2016-2021)
Table 80. Japan Polypeptide Drug Sales by Type (2022-2027) & (MT)
Table 81. Japan Polypeptide Drug Sales Market Share by Type (2022-2027)
Table 82. Japan Polypeptide Drug Sales by Application (2016-2021) & (MT)
Table 83. Japan Polypeptide Drug Sales Market Share by Application (2016-2021)
Table 84. Japan Polypeptide Drug Sales by Application (2022-2027) & (MT)
Table 85. Japan Polypeptide Drug Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Polypeptide Drug Sales (MT) by Company (2016-2021)
Table 87. Southeast Asia Polypeptide Drug Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Polypeptide Drug Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Polypeptide Drug Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Polypeptide Drug Sales by Type (2016-2021) & (MT)
Table 91. Southeast Asia Polypeptide Drug Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Polypeptide Drug Sales by Type (2022-2027) & (MT)
Table 93. Southeast Asia Polypeptide Drug Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Polypeptide Drug Sales by Application (2016-2021) & (MT)
Table 95. Southeast Asia Polypeptide Drug Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Polypeptide Drug Sales by Application (2022-2027) & (MT)
Table 97. Southeast Asia Polypeptide Drug Sales Market Share by Application (2022-2027)
Table 98. India Polypeptide Drug Sales (MT) by Company (2016-2021)
Table 99. India Polypeptide Drug Sales Market Share by Company (2016-2021)
Table 100. India Polypeptide Drug Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Polypeptide Drug Revenue Market Share by Company (2016-2021)
Table 102. India Polypeptide Drug Sales by Type (2016-2021) & (MT)
Table 103. India Polypeptide Drug Sales Market Share by Type (2016-2021)
Table 104. India Polypeptide Drug Sales by Type (2022-2027) & (MT)
Table 105. India Polypeptide Drug Sales Market Share by Type (2022-2027)
Table 106. India Polypeptide Drug Sales by Application (2016-2021) & (MT)
Table 107. India Polypeptide Drug Sales Market Share by Application (2016-2021)
Table 108. India Polypeptide Drug Sales by Application (2022-2027) & (MT)
Table 109. India Polypeptide Drug Sales Market Share by Application (2022-2027)
Table 110. Novartis Corporation Information
Table 111. Novartis Description and Business Overview
Table 112. Novartis Polypeptide Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 113. Novartis Polypeptide Drug Product
Table 114. Novartis Recent Development
Table 115. Merck Serono Corporation Information
Table 116. Merck Serono Description and Business Overview
Table 117. Merck Serono Polypeptide Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 118. Merck Serono Polypeptide Drug Product
Table 119. Merck Serono Recent Development
Table 120. Ferring Pharmaceuticals Corporation Information
Table 121. Ferring Pharmaceuticals Description and Business Overview
Table 122. Ferring Pharmaceuticals Polypeptide Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 123. Ferring Pharmaceuticals Polypeptide Drug Product
Table 124. Ferring Pharmaceuticals Recent Development
Table 125. Ipsen PHarma Biotech Corporation Information
Table 126. Ipsen PHarma Biotech Description and Business Overview
Table 127. Ipsen PHarma Biotech Polypeptide Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 128. Ipsen PHarma Biotech Polypeptide Drug Product
Table 129. Ipsen PHarma Biotech Recent Development
Table 130. Lilly Corporation Information
Table 131. Lilly Description and Business Overview
Table 132. Lilly Polypeptide Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 133. Lilly Polypeptide Drug Product
Table 134. Lilly Recent Development
Table 135. Asahi Kasei Corporation Information
Table 136. Asahi Kasei Description and Business Overview
Table 137. Asahi Kasei Polypeptide Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 138. Asahi Kasei Polypeptide Drug Product
Table 139. Asahi Kasei Recent Development
Table 140. AstraZeneca Corporation Information
Table 141. AstraZeneca Description and Business Overview
Table 142. AstraZeneca Polypeptide Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 143. AstraZeneca Polypeptide Drug Product
Table 144. AstraZeneca Recent Development
Table 145. SciClone Pharmaceuticals Corporation Information
Table 146. SciClone Pharmaceuticals Polypeptide Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 147. SciClone Pharmaceuticals Description and Business Overview
Table 148. SciClone Pharmaceuticals Polypeptide Drug Product
Table 149. SciClone Pharmaceuticals Recent Development
Table 150. Takeda Corporation Information
Table 151. Takeda Polypeptide Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 152. Takeda Description and Business Overview
Table 153. Takeda Polypeptide Drug Product
Table 154. Takeda Recent Development
Table 155. Roche Corporation Information
Table 156. Roche Description and Business Overview
Table 157. Roche Polypeptide Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 158. Roche Polypeptide Drug Product
Table 159. Roche Recent Development
Table 160. Sanofi Corporation Information
Table 161. Sanofi Description and Business Overview
Table 162. Sanofi Polypeptide Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 163. Sanofi Polypeptide Drug Product
Table 164. Sanofi Recent Development
Table 165. Production Base and Market Concentration Rate of Raw Material
Table 166. Key Suppliers of Raw Materials
Table 167. Polypeptide Drug Distributors List
Table 168. Polypeptide Drug Customers List
Table 169. Polypeptide Drug Market Trends
Table 170. Polypeptide Drug Market Drivers
Table 171. Polypeptide Drug Market Challenges
Table 172. Polypeptide Drug Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Polypeptide Drug Product Picture
Figure 2. Global Polypeptide Drug Sales Market Share by Type in 2021 & 2027
Figure 3. Injection Product Picture
Figure 4. Nasal Administration Product Picture
Figure 5. Lung Administration Product Picture
Figure 6. Oral Administration Product Picture
Figure 7. Transdermal Administration Product Picture
Figure 8. Global Polypeptide Drug Sales Market Share by Application in 2021 & 2027
Figure 9. Immunity Regulating Medicine (Allergy Infection and Immune) Examples
Figure 10. Digestive System Drugs (Gastrointestinal Type) Examples
Figure 11. Bone and Connective Tissue Types (Thyroid hormones Drug) Examples
Figure 12. Gynecologic or Obstetric Drug Examples
Figure 13. Tumor Drug Examples
Figure 14. Urinary System Drug Examples
Figure 15. Metabolic Drug (Insulin and Other Hypoglycemic Agents) Examples
Figure 16. Global Polypeptide Drug Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Polypeptide Drug Sales Growth Rate (2016-2027) & (US$ Million)
Figure 18. Global Polypeptide Drug Sales (MT) Growth Rate (2016-2027)
Figure 19. Global Polypeptide Drug Price Trends Growth Rate (2016-2027) (USD/MT)
Figure 20. Global Polypeptide Drug Revenue Market Share by Region: 2016 VS 2021
Figure 21. Global Polypeptide Drug Revenue Market Share by Region: 2021 VS 2027
Figure 22. North America Polypeptide Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. North America Polypeptide Drug Sales (MT) Growth Rate (2016-2027)
Figure 24. Europe Polypeptide Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. Europe Polypeptide Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 26. China Polypeptide Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. China Polypeptide Drug Sales (Million USD) and Growth Rate (2016-2027)
Figure 28. Japan Polypeptide Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 29. Japan Polypeptide Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 30. Southeast Asia Polypeptide Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 31. Southeast Asia Polypeptide Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 32. India Polypeptide Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 33. India Polypeptide Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 34. Global 5 Largest Polypeptide Drug Players Market Share by Revenue in Polypeptide Drug: 2016 & 2020
Figure 35. Polypeptide Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 36. Global Polypeptide Drug Revenue Share by Type (2016-2021)
Figure 37. Global Polypeptide Drug Revenue Growth Rate by Type in 2016 & 2020
Figure 38. Global Polypeptide Drug Revenue Share by Application (2016-2021)
Figure 39. Global Polypeptide Drug Revenue Growth Rate by Application in 2016 & 2020
Figure 40. North America Polypeptide Drug Sales Market Share by Type in 2020
Figure 41. North America Polypeptide Drug Sales Market Share by Application in 2020
Figure 42. Europe Polypeptide Drug Sales Market Share by Type in 2020
Figure 43. Europe Polypeptide Drug Sales Market Share by Application in 2020
Figure 44. China Polypeptide Drug Sales Market Share by Type in 2020
Figure 45. China Polypeptide Drug Sales Market Share by Application in 2020
Figure 46. Japan Polypeptide Drug Sales Market Share by Type in 2020
Figure 47. Japan Polypeptide Drug Sales Market Share by Application in 2020
Figure 48. Southeast Asia Polypeptide Drug Sales Market Share by Type in 2020
Figure 49. Southeast Asia Polypeptide Drug Sales Market Share by Application in 2020
Figure 50. India Polypeptide Drug Sales Market Share by Type in 2020
Figure 51. India Polypeptide Drug Sales Market Share by Application in 2020
Figure 52. Key Raw Materials Price Trend
Figure 53. Manufacturing Cost Structure of Polypeptide Drug
Figure 54. Manufacturing Process Analysis of Polypeptide Drug
Figure 55. Polypeptide Drug Industrial Chain Analysis
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed